{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:51:00Z","timestamp":1790884260296,"version":"4.1.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL-155193"],"award-info":[{"award-number":["R01 HL-155193"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.rpth.2025.103193","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:21:25Z","timestamp":1758788485000},"page":"103193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Emerging pathways in thromboinflammation of sickle cell disease: novel findings in disease pathogenesis"],"prefix":"10.1016","volume":"9","author":[{"given":"Nirupama","family":"Ramadas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5529-7847","authenticated-orcid":false,"given":"Erica","family":"Sparkenbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.103193_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.rpth.2025.103193_bib2","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.4065\/mcp.2010.0554","article-title":"Walter Clement Noel\u2014first patient described with sickle cell disease","volume":"85","author":"Steensma","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.rpth.2025.103193_bib3","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI30920","article-title":"Sickle cell disease: old discoveries, new concepts, and future promise","volume":"117","author":"Frenette","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rpth.2025.103193_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1126\/science.110.2846.64","article-title":"The inheritance of sickle cell anemia","volume":"110","author":"Neel","year":"1949","journal-title":"Science"},{"key":"10.1016\/j.rpth.2025.103193_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.110.2865.543","article-title":"Sickle cell anemia a molecular disease","volume":"110","author":"Pauling","year":"1949","journal-title":"Science"},{"key":"10.1016\/j.rpth.2025.103193_bib6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/ajh.27635","article-title":"FDA approval based on novel surrogate endpoints: lessons from the voluntary withdrawal of voxelotor in sickle cell disease","volume":"100","author":"Kim","year":"2025","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.103193_bib7","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1016\/S2352-3026(24)00384-3","article-title":"Crizanlizumab with or without hydroxyurea in patients with sickle cell disease (STAND): primary analyses from a placebo-controlled, randomised, double-blind, phase 3 trial","volume":"12","author":"Abboud","year":"2025","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.rpth.2025.103193_bib8","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","article-title":"Exagamglogene autotemcel for severe sickle cell disease","volume":"390","author":"Frangoul","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103193_bib9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2117175","article-title":"Biologic and clinical efficacy of LentiGlobin for sickle cell disease","volume":"386","author":"Kanter","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103193_bib10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1182\/bloodadvances.2023011301","article-title":"Managing sickle cell disease and related complications in pregnancy: results of an international Delphi panel","volume":"8","author":"Sharma","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.103193_bib11","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.1213775","article-title":"Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum-infected erythrocytes","volume":"334","author":"Cyrklaff","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.rpth.2025.103193_bib12","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.rpth.2025.103193_bib13","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.annemergmed.2020.08.009","article-title":"Trends in sickle cell disease-related mortality in the United States, 1979 to 2017","volume":"76","author":"Payne","year":"2020","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.rpth.2025.103193_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/bloodadvances.2021006281","article-title":"Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance","volume":"7","author":"Johnson","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.103193_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/03630269.2023.2301026","article-title":"Hypercoagulability in sickle cell disease: a thrombo-inflammatory mechanism","volume":"47","author":"Hamali","year":"2023","journal-title":"Hemoglobin"},{"key":"10.1016\/j.rpth.2025.103193_bib16","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.3324\/haematol.2019.239343","article-title":"Thromboinflammatory mechanisms in sickle cell disease\u2014challenging the hemostatic balance","volume":"105","author":"Conran","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2025.103193_bib17","first-page":"14","article-title":"Overview of the clinical manifestations of sickle cell disease","volume":"6","author":"Vichinsky","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.rpth.2025.103193_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.rpth.2025.103193_bib19","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2018-11-882993","article-title":"Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms","volume":"133","author":"Jackson","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/CH-189013","article-title":"Hypercoagulable state in sickle cell disease","volume":"68","author":"Faes","year":"2018","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.rpth.2025.103193_bib21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2141.2012.09065.x","article-title":"Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis","volume":"157","author":"Setty","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103193_bib22","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/MBC.0000000000000494","article-title":"Tissue factor-positive monocytes expression in children with sickle cell disease: clinical implication and relation to inflammatory and coagulation markers","volume":"27","author":"Ragab","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2025.103193_bib23","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1172\/JCI1932","article-title":"Tissue factor expression by endothelial cells in sickle cell anemia","volume":"101","author":"Solovey","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rpth.2025.103193_bib24","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/j.1538-7836.2008.03177.x","article-title":"Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia","volume":"6","author":"Setty","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103193_bib25","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1177\/15353702221106475","article-title":"Evaluation of the mechanisms of heme-induced tissue factor activation: contribution of innate immune pathways","volume":"247","author":"Hounkpe","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.rpth.2025.103193_bib26","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1182\/blood-2015-11-681114","article-title":"Thrombin-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease","volume":"127","author":"Sparkenbaugh","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib27","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-04-424143","article-title":"Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease","volume":"120","author":"Chantrathammachart","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib28","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1182\/blood-2015-01-625707","article-title":"Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice","volume":"126","author":"Arumugam","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib29","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood-2013-08-523936","article-title":"Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease","volume":"123","author":"Sparkenbaugh","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib30","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1182\/blood.2019003543","article-title":"Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease","volume":"135","author":"Sparkenbaugh","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib31","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/j.1538-7836.2012.04861.x","article-title":"Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia","volume":"10","author":"Colella","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103193_bib32","article-title":"A comparative analysis of hydroxyurea treatment on coagulation profile among sickle cell anaemia children in Lagos, Nigeria","volume":"2024","author":"Kene-Udemezue","year":"2024","journal-title":"Adv Hematol"},{"key":"10.1016\/j.rpth.2025.103193_bib33","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.3390\/jcm13216404","article-title":"The current role of hydroxyurea in the treatment of sickle cell anemia","volume":"13","author":"Lopez Rubio","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.rpth.2025.103193_bib34","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/jth.14972","article-title":"High molecular weight kininogen contributes to early mortality and kidney dysfunction in a mouse model of sickle cell disease","volume":"18","author":"Sparkenbaugh","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103193_bib35","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood.2022017074","article-title":"Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease","volume":"141","author":"Sparkenbaugh","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib36","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/jth.13416","article-title":"Thrombin generation and cell-dependent hypercoagulability in sickle cell disease","volume":"14","author":"Whelihan","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103193_bib37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0022-2143(99)90149-X","article-title":"Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease","volume":"134","author":"Westerman","year":"1999","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.rpth.2025.103193_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000204390","article-title":"Blood proteins C and S in sickle cell disease","volume":"90","author":"el-Hazmi","year":"1993","journal-title":"Acta Haematol"},{"key":"10.1016\/j.rpth.2025.103193_bib39","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1182\/blood-2010-08-301366","article-title":"Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S","volume":"117","author":"Gavins","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib40","first-page":"4125","article-title":"Heme induced loss of renovascular endothelial protein C receptor promotes chronic kidney disease in sickle mice","volume":"117","author":"Chen","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajh.25384","article-title":"Critical role of C5a in sickle cell disease","volume":"94","author":"Vercellotti","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.103193_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adl4922","article-title":"Complement is activated in patients with acute chest syndrome caused by sickle cell disease and represents a therapeutic target","volume":"17","author":"Chonat","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.rpth.2025.103193_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96910","article-title":"Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles","volume":"3","author":"Merle","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.rpth.2025.103193_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40164-021-00249-8","article-title":"Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy","volume":"10","author":"Gavriilaki","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.rpth.2025.103193_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2022.06.018","article-title":"MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease","volume":"249","author":"Belcher","year":"2022","journal-title":"Transl Res"},{"key":"10.1016\/j.rpth.2025.103193_bib46","doi-asserted-by":"crossref","first-page":"20221","DOI":"10.1074\/jbc.M610737200","article-title":"Characterization of heme as activator of Toll-like receptor 4","volume":"282","author":"Figueiredo","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rpth.2025.103193_bib47","article-title":"Soluble MD-2 and heme in sickle cell disease plasma promote pro-inflammatory signaling in endothelial cells","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2025.103193_bib48","article-title":"Endothelial TLR4 expression mediates vaso-occlusive crisis in sickle cell disease","volume":"11","author":"Beckman","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2025.103193_bib49","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood.2021014894","article-title":"HbS promotes TLR4-mediated monocyte activation and proinflammatory cytokine production in sickle cell disease","volume":"140","author":"Allali","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib50","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/bjh.14663","article-title":"Haem augments and iron chelation decreases toll-like receptor 4 mediated inflammation in monocytes from sickle cell patients","volume":"181","author":"Dagur","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103193_bib51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bcmd.2017.05.009","article-title":"Oxidative pathways in the sickle cell and beyond","volume":"70","author":"Alayash","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.rpth.2025.103193_bib52","doi-asserted-by":"crossref","first-page":"E4110","DOI":"10.1073\/pnas.1405023111","article-title":"Hemolysis-induced lethality involves inflammasome activation by heme","volume":"111","author":"Dutra","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rpth.2025.103193_bib53","doi-asserted-by":"crossref","first-page":"24430","DOI":"10.1074\/jbc.M703570200","article-title":"Heme induces neutrophil migration and reactive oxygen species generation through signaling pathways characteristic of chemotactic receptors","volume":"282","author":"Porto","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rpth.2025.103193_bib54","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1182\/blood-2011-08-375303","article-title":"Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production","volume":"119","author":"Fortes","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib55","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1182\/blood.V98.3.860","article-title":"Characterization of the phosphatidylserine-exposing subpopulation of sickle cells","volume":"98","author":"de Jong","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib56","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/bjh.18799","article-title":"Piezo1 activation augments sickling propensity and the adhesive properties of sickle red blood cells in a calcium-dependent manner","volume":"202","author":"Nader","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103193_bib57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tracli.2008.05.002","article-title":"Role of Lu\/BCAM in abnormal adhesion of sickle red blood cells to vascular endothelium","volume":"15","author":"El Nemer","year":"2008","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.rpth.2025.103193_bib58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tracli.2008.05.001","article-title":"Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea","volume":"15","author":"Cartron","year":"2008","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.rpth.2025.103193_bib59","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood.2019001643","article-title":"Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways","volume":"135","author":"Noubouossie","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib60","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib61","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1182\/blood-2009-04-217950","article-title":"Placenta growth factor in sickle cell disease: association with hemolysis and inflammation","volume":"115","author":"Brittain","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1076029611420992","article-title":"Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell disease","volume":"18","author":"Qari","year":"2012","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.rpth.2025.103193_bib63","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13178","article-title":"Combined hydroxyurea and ETA receptor blockade reduces renal injury in the humanized sickle cell mouse","volume":"225","author":"Taylor","year":"2019","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.rpth.2025.103193_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162652","article-title":"Albuminuria is associated with endothelial dysfunction and elevated plasma endothelin-1 in sickle cell anemia","volume":"11","author":"Ataga","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2025.103193_bib65","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.thromres.2020.08.004","article-title":"The domino effect triggered by the tethered ligand of the protease activated receptors","volume":"196","author":"Han","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103193_bib66","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1182\/blood-2015-02-355974","article-title":"Activated protein C: biased for translation","volume":"125","author":"Griffin","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib67","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1182\/bloodadvances.2023011907","article-title":"Biased agonism of protease-activated receptor-1 regulates thrombo-inflammation in murine sickle cell disease","volume":"8","author":"Ramadas","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.103193_bib68","article-title":"The APC-EPCR-PAR1 axis in sickle cell disease","volume":"10","author":"Ramadas","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.rpth.2025.103193_bib69","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/MOH.0000000000000755","article-title":"Hidden behind thromboinflammation: revealing the roles of von Willebrand factor in sickle cell disease pathophysiology","volume":"30","author":"Vital","year":"2023","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.rpth.2025.103193_bib70","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1160\/TH08-10-0677","article-title":"Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease","volume":"101","author":"Zhou","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103193_bib71","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jtha.2022.10.016","article-title":"Treatment with recombinant ADAMTS13, alleviates hypoxia\/reoxygenation-induced pathologies in a mouse model of human sickle cell disease","volume":"21","author":"Rossato","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103193_bib72","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/bjh.18616","article-title":"Sickle red blood cell-derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factor","volume":"201","author":"An","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103193_bib73","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207592119","article-title":"Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease","volume":"119","author":"Shi","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rpth.2025.103193_bib74","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1111\/jth.15804","article-title":"Contribution of ADAMTS13-independent VWF regulation in sickle cell disease","volume":"20","author":"Hunt","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103193_bib75","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood.2023021583","article-title":"Clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in sickle cell anemia mice","volume":"143","author":"Shi","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib76","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1172\/JCI64578","article-title":"Extracellular hemin crisis triggers acute chest syndrome in sickle mice","volume":"123","author":"Ghosh","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rpth.2025.103193_bib77","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2013-10-529982","article-title":"Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease","volume":"123","author":"Chen","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib78","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/ATVBAHA.114.304114","article-title":"Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms","volume":"34","author":"Gould","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2025.103193_bib79","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1084\/jem.20130664","article-title":"The PSGL-1-L-selectin signaling complex regulates neutrophil adhesion under flow","volume":"210","author":"Stadtmann","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.rpth.2025.103193_bib80","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/ajh.20059","article-title":"Inflammatory potential of neutrophils detected in sickle cell disease","volume":"76","author":"Lum","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.103193_bib81","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1172\/JCI92880","article-title":"Factor XII and uPAR upregulate neutrophil functions to influence wound healing","volume":"128","author":"Stavrou","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rpth.2025.103193_bib82","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-2143(97)90005-6","article-title":"Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia","volume":"129","author":"Wun","year":"1997","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.rpth.2025.103193_bib83","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/01.ATV.0000220374.00602.a2","article-title":"Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation","volume":"26","author":"Lee","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2025.103193_bib84","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood-2006-12-061697","article-title":"Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin","volume":"110","author":"Villagra","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib85","article-title":"High-mobility group box 1 increases platelet surface P2Y12 and platelet activation in sickle cell disease","volume":"9","author":"Nolfi-Donegan","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.rpth.2025.103193_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102205","article-title":"Heme stimulates platelet mitochondrial oxidant production to induce targeted granule secretion","volume":"48","author":"Annarapu","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.rpth.2025.103193_bib87","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2016-09-741298","article-title":"Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice","volume":"129","author":"McDonald","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib88","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/01.ATV.20.10.2322","article-title":"Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression","volume":"20","author":"Lindmark","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2025.103193_bib89","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3324\/haematol.2020.246488","article-title":"Heme induces human and mouse platelet activation through C-type-lectin-like receptor-2","volume":"106","author":"Bourne","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2025.103193_bib90","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI20986","article-title":"Central role of the P2Y12 receptor in platelet activation","volume":"113","author":"Dorsam","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rpth.2025.103193_bib91","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood-2017-05-787259","article-title":"Procoagulant platelets: generation, function, and therapeutic targeting in thrombosis","volume":"130","author":"Agbani","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib92","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-3476(83)80258-3","article-title":"Trial of low doses of aspirin as prophylaxis in sickle cell disease","volume":"102","author":"Greenberg","year":"1983","journal-title":"J Pediatr"},{"key":"10.1016\/j.rpth.2025.103193_bib93","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000206360","article-title":"Treatment of sickle cell diseases with aspirin","volume":"72","author":"Zago","year":"1984","journal-title":"Acta Haematol"},{"key":"10.1016\/j.rpth.2025.103193_bib94","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.thromres.2014.07.035","article-title":"Platelet activation biomarkers in Berkeley sickle cell mice and the response to prasugrel","volume":"134","author":"Ohno","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103193_bib95","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3109\/09537104.2014.940887","article-title":"The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell disease","volume":"26","author":"Jakubowski","year":"2015","journal-title":"Platelets"},{"key":"10.1016\/j.rpth.2025.103193_bib96","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40262-017-0556-y","article-title":"Population pharmacokinetic and exposure-response analyses of prasugrel in pediatric patients with sickle cell anemia","volume":"57","author":"Moser","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.rpth.2025.103193_bib97","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1160\/TH16-09-0731","article-title":"Real-time dose adjustment using point-of-care platelet reactivity testing in a double-blind study of prasugrel in children with sickle cell anaemia","volume":"117","author":"Jakubowski","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103193_bib98","article-title":"The role of antiplatelet in the management of sickle cell disease patients","volume":"15","author":"Naramreddy","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.rpth.2025.103193_bib99","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/bjh.15646","article-title":"Ticagrelor does not impact patient-reported pain in young adults with sickle cell disease: a multicentre, randomised phase IIb study","volume":"184","author":"Kanter","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103193_bib100","article-title":"Impaired platelet purinergic signaling in sickle cell disease","volume":"203","author":"Brzoska","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rpth.2025.103193_bib101","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/bloodadvances.2018021709","article-title":"The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1\/TLR4 and Bruton tyrosine kinase","volume":"2","author":"Vogel","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.103193_bib102","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjmed.2012.12.016","article-title":"Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication","volume":"126","author":"Naik","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2025.103193_bib103","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bjh.14655","article-title":"Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality","volume":"178","author":"Brunson","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103193_bib104","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ajh.25508","article-title":"High incidence of venous thromboembolism recurrence in patients with sickle cell disease","volume":"94","author":"Brunson","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.103193_bib105","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1182\/bloodadvances.2019001142","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults","volume":"4","author":"DeBaun","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.103193_bib106","doi-asserted-by":"crossref","first-page":"852","DOI":"10.7150\/ijbs.77434","article-title":"Regulating neutrophil PAD4\/NOX-dependent cerebrovasular thromboinflammation","volume":"19","author":"Ansari","year":"2023","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.rpth.2025.103193_bib107","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood.2020009166","article-title":"Targeting the AnxA1\/Fpr2\/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease","volume":"137","author":"Ansari","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib108","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCULATIONAHA.118.039345","article-title":"Novel role for the AnxA1-Fpr2\/ALX signaling axis as a key regulator of platelet function to promote resolution of inflammation","volume":"140","author":"Senchenkova","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.103193_bib109","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/ATVBAHA.116.308038","article-title":"2016 Scientific Sessions Sol Sherry Distinguished Lecturer in Thrombosis: thrombotic stroke: neuroprotective therapy by recombinant-activated protein C","volume":"36","author":"Griffin","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2025.103193_bib110","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1182\/bloodadvances.2023010101","article-title":"Natural history and variability in albuminuria in pediatric and murine sickle cell anemia","volume":"7","author":"Kasztan","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.103193_bib111","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/bjh.20040","article-title":"Acute intravascular haemolysis rapidly shifts the balance of angiogenic factors and accelerates neovascularization in vivo","volume":"206","author":"Gotardo","year":"2025","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103193_bib112","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12288-018-1018-x","article-title":"VEGF promoter region 18-bp insertion-deletion polymorphism in sickle cell disease patients with microalbuminuria: a pilot study","volume":"35","author":"Amle","year":"2019","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.rpth.2025.103193_bib113","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/bph.13380","article-title":"Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species","volume":"173","author":"Heimlich","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.rpth.2025.103193_bib114","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1182\/bloodadvances.2023011542","article-title":"Isoquercetin for thromboinflammation in sickle cell disease: a randomized double-blind placebo-controlled trial","volume":"8","author":"Lizarralde-Iragorri","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.103193_bib115","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1172\/JCI61303","article-title":"Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury","volume":"122","author":"Caudrillier","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rpth.2025.103193_bib116","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89761","article-title":"Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli","volume":"2","author":"Bennewitz","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.rpth.2025.103193_bib117","article-title":"Platelet extracellular vesicles drive inflammasome-IL1beta-dependent lung injury in sickle cell disease","author":"Vats","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rpth.2025.103193_bib118","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood.2021014552","article-title":"Liver-to-lung microembolic NETs promote gasdermin D-dependent inflammatory lung injury in sickle cell disease","volume":"140","author":"Vats","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib119","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.amjmed.2004.03.034","article-title":"Pulmonary hypertension in sickle cell disease","volume":"117","author":"Ataga","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2025.103193_bib120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ajem.2022.06.018","article-title":"High risk and low prevalence diseases: Acute chest syndrome in sickle cell disease","volume":"58","author":"Koehl","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.rpth.2025.103193_bib121","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ppul.23932","article-title":"Airway inflammation in sickle cell disease\u2014a translational perspective","volume":"53","author":"De","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rpth.2025.103193_bib122","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103193_bib123","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.5858\/2001-125-1436-PTAIPW","article-title":"Pulmonary thrombotic arteriopathy in patients with sickle cell disease","volume":"125","author":"Adedeji","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.rpth.2025.103193_bib124","first-page":"858","article-title":"Pulmonary changes in sickle cell disease","volume":"103","author":"Oppenheimer","year":"1971","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.rpth.2025.103193_bib125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/blood-2009-09-244830","article-title":"High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension","volume":"116","author":"Sundaram","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007956","article-title":"Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease","volume":"4","author":"Niu","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2025.103193_bib127","article-title":"The worst things in life are free: the role of free heme in sickle cell disease","volume":"11","author":"Gbotosho","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2025.103193_bib128","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2012-04-383430","article-title":"Sickle cell pain: a critical reappraisal","volume":"120","author":"Ballas","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MOH.0000000000000491","article-title":"Pain and sickle cell disease","volume":"26","author":"Aich","year":"2019","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.rpth.2025.103193_bib130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.25308","article-title":"Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: a SUSTAIN study analysis","volume":"94","author":"Kutlar","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.103193_bib131","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1182\/blood.2020006020","article-title":"Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers","volume":"137","author":"Pittman","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1493904","article-title":"Missing the mark(ers): circulating endothelial cells and endothelial-derived extracellular vesicles are elevated in sickle cell disease plasma","volume":"15","author":"Beckman","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2025.103193_bib133","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2003-03-0693","article-title":"Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes","volume":"102","author":"Shet","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib134","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MOH.0000000000000773","article-title":"The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease","volume":"30","author":"Beckman","year":"2023","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.rpth.2025.103193_bib135","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1182\/blood.2022019282","article-title":"Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation","volume":"142","author":"Ivy","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103193_bib136","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3324\/haematol.2018.198622","article-title":"Factor H interferes with the adhesion of sickle red cells to vascular endothelium: a novel disease-modulating molecule","volume":"104","author":"Lombardi","year":"2019","journal-title":"Haematologica"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925005175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925005175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:35:23Z","timestamp":1773182123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037925005175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":136,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2475037925005175"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103193","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging pathways in thromboinflammation of sickle cell disease: novel findings in disease pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103193"}}